Dolby Laboratories filings document the regulatory disclosures of a technology licensing and cinema-products company whose Class A common stock trades on the New York Stock Exchange under DLB. Recent Form 8-K reports furnish quarterly and annual financial results, dividend declarations for Class A and Class B common stock, and related exhibits.
The company’s proxy and governance filings cover director elections, advisory executive-compensation votes, auditor ratification and executive incentive compensation arrangements. The filings also describe Dolby’s dual-class voting structure, with Class A and Class B common stock voting together on most stockholder matters except where law requires otherwise.
Dolby Laboratories, Inc. (DLB) adopted a fiscal 2027 executive cash bonus plan and approved an executive severance policy. President and Chief Executive Officer Marc Whitten’s fiscal 2027 bonus will be paid at 100% of target, equal to 100% of base salary. Other participating officers’ awards depend on non-GAAP operating income, revenue and other goals, subject to Committee discretion; plan funding is capped at 150% of target.
Eligible named executives are Andy Sherman (Executive Vice President, General Counsel, and Corporate Secretary), Robert Park (Senior Vice President and Chief Financial Officer), John Couling (Senior Vice President, Entertainment), and Shriram Revankar (Senior Vice President, Advanced Technology Group). For a Qualified Termination outside the 60-days-before/12-months-after Change in Control window, severance includes 100% of base salary, 100% of target incentive, a prorated performance-based incentive and up to 12 months of COBRA. Within that window, cash terms include 150% of base salary, 150% of target incentive and a prorated target incentive, plus up to 18 months of COBRA. Equity awards may also vest on an accelerated basis; benefits require a timely signed, non-revoked release.
Dolby Laboratories, Inc. (DLB) has a Schedule 13G amendment reporting Morgan Stanley’s beneficial ownership of 3,044,622 Class A shares, or 5.1% of the class, as of September 30, 2026. Morgan Stanley reported shared voting power over 2,556,623 shares and shared dispositive power over 2,916,405 shares. Atlanta Capital Management Company, LLC reported beneficial ownership of 2,101,646 shares, or 3.5%, and stated that it had ceased to be the beneficial owner of more than 5% of the class.
Dolby Laboratories, Inc. (DLB) is the issuer in a joint ownership report by First Trust Portfolios L.P., First Trust Advisors L.P., and The Charger Corporation. Each listed beneficial ownership of 3,023,033 common shares, or 5.09% of the class. First Trust Advisors and The Charger Corporation each reported shared voting power over 3,005,306 shares and shared dispositive power over 3,023,033 shares; First Trust Portfolios reported no voting power and shared dispositive power over 17,727 shares. Each entity disclaimed beneficial ownership. Trustees vote shares held by certain unit investment trusts, ordinarily as closely as possible to the manner and general proportion in which other holders' shares are voted.
Dolby Laboratories, Inc. (DLB) is the issuer in Amendment No. 3 to a Schedule 13G reporting beneficial ownership of its Class A common stock by The Bank of New York Mellon Corporation and three other reporting persons. The cover pages list 5,118,575 shares (8.6%) for The Bank of New York Mellon Corporation, 4,433,440 shares (7.5%) each for BNY Mellon IHC, LLC and MBC Investments Corp, and 3,926,610 shares (6.6%) for Newton Investment Management North America, LLC.
The report says the securities are beneficially owned by The Bank of New York Mellon Corporation and its direct or indirect subsidiaries in various fiduciary capacities; another entity is entitled to dividends or sale proceeds in every instance, and no other person's interest exceeds 5%. It also states that the filing is not an admission of beneficial ownership for purposes of Sections 13(d) or 13(g).
Dolby Laboratories, Inc. SVP, Entertainment John D. Couling exercised options for 7,667 Class A common shares on October 1, 2026, at a $45.50 exercise price, then sold 6,831 shares at a weighted average price of $58.7164 and 836 shares at a weighted average price of $59.3275. The sales were reported under a Rule 10b5-1 trading plan. The option had been granted for 46,000 shares and was fully vested and exercisable; post-transaction holdings included 103,190 shares underlying restricted stock units subject to forfeiture until vesting.
For Dolby Laboratories, Inc. (DLB), the Marital Trust transferred 24,108,162 shares of Class B Common Stock to the Dagmar Dolby Trust on October 2, 2026. The transfer was made solely for tax and estate planning, for no value and without payment or receipt of funds or other consideration. Class B shares are convertible at no cost into Class A shares on a 1-for-1 basis at the holder’s election.
Dolby Laboratories, Inc. (DLB) lists officer John Couling, signing as John David Couling, for a proposed sale of 7,667 common shares, with an aggregate market value of $450,689.26 and an approximate sale date of October 1, 2026, through Morgan Stanley Smith Barney LLC on the NYSE. The notice says the shares were acquired from the issuer through a cash stock-option exercise on October 1, 2026. It also reports sales of 7,667 shares on September 1, 2026, with gross proceeds of $468,032.02, and 7,667 shares on August 3, 2026, with gross proceeds of $460,003.90.
Dolby Laboratories, Inc. (DLB) reported that its President and CEO, Marc Whitten, received two equity awards on September 15, 2026. He was granted 160,256 restricted stock units under Dolby’s 2026 Inducement Stock Plan that vest in four equal installments starting March 15, 2027 and then on each six‑month anniversary, subject to continued employment. Each unit converts into one share of Class A common stock upon vesting and remains subject to forfeiture until it vests.
Whitten also received 600,000 performance-based restricted stock units under the same plan, split into tranches of 150,000, 150,000, 100,000, 100,000 and 100,000 units. These tranches become eligible to vest if Dolby’s stock price reaches $75, $100, $125, $150 and $175, respectively, averaged over a consecutive 60 trading-day period within a five-year performance window, with adjustments for dividends and capitalization changes. Eligible units vest upon certification of each stock-price goal, contingent on Whitten’s continued service as CEO.
Dolby Laboratories, Inc. (symbol: DLB) is the issuer of record for a Form 4 filing submitted to the SEC. Couling John D reported acquisition or exercise transactions in this Form 4 filing.
Dolby Laboratories, Inc. executive John D. Couling, SVP, Entertainment, received an equity compensation grant of 48,076 restricted stock units (RSUs) of Class A Common Stock on September 15, 2026 under the company’s 2020 Stock Plan. All RSUs vest on September 15, 2028, subject to his continued service, with each unit delivering one share upon vesting. Following this award, he holds 166,803 Class A shares in total, including 103,190 shares underlying unvested RSUs that remain subject to forfeiture. No Rule 10b5-1 trading plan is reported.
Dolby Laboratories, Inc. (DLB) reported that executive vice president, general counsel and secretary Mark Andrew Sherman received a grant of 48,076 restricted stock units of Class A common stock on September 15, 2026 under the company’s 2020 Stock Plan. These units vest 100% on September 15, 2028, contingent on his continued service, with each unit representing a right to receive one Class A share upon vesting. Following this award, Sherman holds 119,024 Class A shares directly, including 101,712 shares underlying unvested restricted stock units and 385 shares acquired through the Employee Stock Purchase Plan. No Rule 10b5-1 trading plan is reported.